IntroductionContinual myeloid leukemia (CML) is a hematological neoplasm initiated by the fusion gene BCR-ABL (1). The introduction of tyrosine kinase inhibitors (TKIs), comparable...
The Meals and Drug Administration (FDA) authorised Tepylute (SH-105), a ready-to-dilute type of the most cancers drug thiotepa, for sufferers with breast or...
